FDA Inspection 1040785 — Nesher Pharmaceuticals (USA) LLC
The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on Jan 11, 2018 in Bridgeton, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgeton, MO (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)